Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
NONO
NoNO is a clinical-stage biotherapeutics company that develops pharmaceuticals for common health disorders.
Sector
Subsector
Location
total rounds
total raised
Promentis Pharmaceuticals
Promentis Pharmaceuticals develops antipsychotic drugs to treat schizophrenia.
Sector
Subsector
Keywords
Location
total rounds
total raised
Aires Pharmaceuticals
Aires Pharmaceuticals develops therapies to treat pulmonary disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
NRx Pharmaceuticals
NRx Pharmaceuticals develops therapeutics for severe mental disorders and respiratory diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds13
Number of Funding Rounds
Money Raised
Their latest funding was raised on 07.11.2022. Their latest round Post-IPO Equity
Sagard Healthcare Royalty Partners
Sagard Healthcare Royalty Partners is the royalty investment arm of Sagard Holdings, a private-equity firm.
Sector
Subsector
Keywords
count Of Investments
Co-Investors
Investors8
Number of lead investors
Number of investors
Sagard Healthcare Royalty Partners
Sagard Healthcare Royalty Partners is the royalty investment arm of Sagard Holdings, a private-equity firm.
Sector
Subsector
Keywords
count Of Investments
Raja Manchanda
Partner
current job
Foundation Medical Partners
Foundation Medical Partners is a healthcare technology venture capital firm in the US.
Sector
Subsector
Location
count Of Investments
count Of Exists
RMI Partners
RMI Partners is a venture capital firm that focuses on investing in innovative biopharmaceutical products and medical technologies.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders1
Harry H. Penner
Mr. Penner is Founder, Chairman and Chief Executive Officer of Nascent BioScience, LLC, a firm engaged in the creation and development of new biotechnology companies founded in September 2001. Mr. Penner is a Founder of New Haven Pharmaceuticals (of which he is Chairman and Chief Executive Officer), Prevention Pharmaceuticals, Affinimark Technologies, Rib-X Pharmaceuticals, RxGen, MAK Scientific, and Celldex Therapeutics. He was President, Chief Executive Officer, and Vice Chairman of Neurogen Corporation from 1993 to 2001. From 1985 to 1993 he was an Executive Vice President of Novo Nordisk A/S, serving from 1988 to 1993 as Executive Vice President for North America and President, Novo Nordisk of North America, and from 1985 to 1988 as the company's Executive Vice President and General Counsel in Denmark. He has served as BioScience Advisor to the Governor and the State of Connecticut, as Co-Chair of Connecticut United for Research Excellence, and as Chair of the Connecticut Board of Governors of Higher Education. He currently serves on the Boards Rib-X, New Haven Pharmaceuticals, Prevention Pharmaceuticals, and Affinimark. Mr. Penner holds a B.A. from the University of Virginia, a J.D. from Fordham University, and an L.L.M. in International Law from New York University.
current job
organization founded
Harry H. Penner
Employee Profiles20
Romy Nocera
Director, scientific and medical education and communication
Martha Manning
Vice President, General Counsel, and Corporate Secretary
Activity
Recent News17
The graph reveals the ratio (%) of positive news articles in a chosen time range